International Journal of Hematology

, Volume 108, Issue 4, pp 384–389 | Cite as

Molecular characterization of Hb H disease in southern Thailand

  • Kesara Nittayaboon
  • Chamnong NopparatanaEmail author
Original Article


Genotypes of 260 individuals with hemoglobin H (Hb H) disease originating from various provinces in southern Thailand were characterized by multiplex PCR (M-PCR) and reverse dot blot hybridization (RDB). M-PCR was used to amplify target fragments and then hybridized with allele-specific oligonucleotide (ASO) probes which were bound on a nylon membrane. A total of eight α-thalassemia (α-thal) mutations, which produced eight Hb H disease genotypes (α0-thal/α+-thal), were detected. The most common form of α0-thal was −SEA with a frequency of 99.23%. The other form (0.77%) of α0-thal mutation was a THAI deletion (−THAI). The deletional α+-thal mutations comprised 3.7 kb (-α3.7) and 4.2 kb (-α4.2) deletions which were found in 172 (66.15%) and 5 (1.92%) alleles, respectively. The incidence of non-deletional α+-thal in decreasing order was Hb Constant Spring (Hb CS, αCS) 28.85%, Hb Quong Sze (Hb QS, αQS) 1.54%, and Hb Paksé (Hb PS, αPS) 0.77%. The genotype characterization of Hb H disease and the development of the RDB technic for detection of α-thal mutations presented in this study enable the prenatal diagnosis of Hb Bart’s hydrops fetalis syndrome.


Molecular Hb H disease Southern Thailand 



The authors thank the staff of the Hematology and Thalassemia Laboratory of the Department of Pathology, Faculty of Medicine, Prince of Songkla University for the technical support. This work was supported by a Grant (REC 57-005-04-6-2) from the Faculty of Medicine, Prince of Songkla University. The sponsors of this study are public or nonprofit organizations that support science in general.

Author contributions

KN performed the research, analyzed the data, and wrote the manuscript. CN designed the research study, interpreted the data, and edited the manuscript. Final version of the article was read and approved by all of the authors.

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interests regarding the publication of this paper.


  1. 1.
    Origa R, Moi P. (2016) Alpha-Thalassemia. GeneReviews® [Internet]. (cited 2017 Oct 20).
  2. 2.
    Chui DHK. Thalassemia. Hb H disease and Hb Bart’s hydrops fetalis. Ann N Y Acad Sci. 2005;1054:25–32.CrossRefPubMedGoogle Scholar
  3. 3.
    Xu XM, Zhou YQ, Luo GX, Liao C, Zhou M, Chen PY, et al. The prevalence and spectrum of alpha and beta thalassaemia in Guangdong province: implications for the future health burden and population screening. J Clin Pathol. 2004;57:517–22.CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Fucharoen S, Winichagoon P. Haemoglobinopathies in Southeast Asia. Indian J Med Res. 2011;134:498–506.PubMedPubMedCentralGoogle Scholar
  5. 5.
    Chui DHK, Fucharoen S, Chan V. Hemoglobin H disease: not necessarily a benign disorder. Blood. 2003;101:791–800.CrossRefPubMedGoogle Scholar
  6. 6.
    Pharephan S, Sirivatanapa P, Makonkawkeyoon S, Tuntiwechapikul W, Makonkawkeyoon L. Prevalence of α-thalassaemia genotypes in pregnant women in northern Thailand. Indian J Med Res. 2016;143:315–22.CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Giardine B, van Baal S, Kaimakis P, Riemer C, Miller W, Samara M, et al. HbVar database of human hemoglobin variants and thalassemia mutations: 2007 update. Hum Mutat. 2007;28:206.CrossRefPubMedGoogle Scholar
  8. 8.
    Lin M, Zhu JJ, Wang Q, Xie LX, Lu M, Wang JL, et al. Development and evaluation of a reverse dot blot assay for the simultaneous detection of common alpha and beta thalassemia in Chinese. Blood Cells Mol Dis. 2012;48:86–90.CrossRefPubMedGoogle Scholar
  9. 9.
    Chan V, Yam I, Chen FE, Chan TK. A reverse dot-blot method for rapid detection of non-deletion alpha thalassaemia. Br J Haematol. 1999;104:513–5.CrossRefPubMedGoogle Scholar
  10. 10.
    Ye BC1, Zhang Z, Lei Z. Oligonucleotide array for detection of common severe determinants of alpha thalassemia. J Biotechnol. 2005;115:1–9.CrossRefPubMedGoogle Scholar
  11. 11.
    Zesong L, Ruijun G, Wen Z. Rapid detection of deletional alpha-thalassemia by an oligonucleotide microarray. Am J Hematol. 2005;80:306–8.CrossRefPubMedGoogle Scholar
  12. 12.
    Baysal E, Huisman THJ. Detection of common deletional α-thalassaemia-2 determinants by PCR. Am J Hematol. 1994;46:208–13.CrossRefPubMedGoogle Scholar
  13. 13.
    Chong SS, Boehm CD, Higgs DR, Cutting GR. Single-tube multiplex-PCR screen for common deletional determinants of α-thalassemia. Blood. 2000;95:360–2.PubMedGoogle Scholar
  14. 14.
    Liu YT, Old JM, Fisher CA, Weatherall DJ, Clegg JB. Rapid detection of α-thalassaemia deletions andα-globin gene triplication by multiplex polymerase chain reactions. Br J Haematol. 2000;108:295–9.CrossRefPubMedGoogle Scholar
  15. 15.
    Chen TP, Liu TC, Chang CS, Chang JG, Tsai HJ, Lin SF. PCR-based analysis of alpha-thalassemia in Southern Taiwan. Int J Hematol. 2002;75:277–80.CrossRefPubMedGoogle Scholar
  16. 16.
    Foglietta E, Bianco I, Maggio A, Giambona A. Rapid detection of six common Mediterranean and three non-Mediterranean α-thalassemia point mutations by reverse dot blot. Am J Hematol. 2003;74:191–5.CrossRefPubMedGoogle Scholar
  17. 17.
    Puehringer H, Najmabadi H, Law HY, Krugluger W, Viprakasit V, Pissard S, et al. Validation of a reverse-hybridization StripAssay for the simultaneous analysis of common alpha-thalassemia point mutations and deletions. Clin Chem Lab Med. 2007;45:605–10.CrossRefPubMedGoogle Scholar
  18. 18.
    Winichagoon P, Fucharoen S, Wasi P. The molecular basis of alpha-thalassemia in Thailand. Southeast Asian J Trop Med Public Health. 1992;23(Suppl 2):7–13.PubMedGoogle Scholar
  19. 19.
    Lithanatudom P, Khampan P, Duncan RS, Svasti S, Fucharoen S, Kangwanpong D, et al. The prevalence of alpha-thalassemia amongst Tai and Mon-Khmer ethnic groups residing in northern Thailand: a population-based study. Hematology. 2016;21:480–5.CrossRefPubMedGoogle Scholar
  20. 20.
    Laosombat V, Viprakasit V, Chotsampancharoen T, Wongchanchailert M, Khodchawan S, Chinchang W, et al. Clinical features and molecular analysis in Thai patients with Hb H disease. Ann Hematol. 2009;88:1185–92.CrossRefPubMedGoogle Scholar
  21. 21.
    Pornprasert S, Punyamung M. Detection of compound heterozygous of Hb constant spring and Hb Q-Thailand by capillary electrophoresis and high performance liquid chromatography. Indian J Hematol Blood Transfus. 2015;31:229–32.CrossRefPubMedGoogle Scholar
  22. 22.
    Charoenkwan P, Taweephon R, Sae-Tung R, Thanarattanakorn P, Sanguansermsri T. Molecular and clinical features of Hb H disease in northern Thailand. Hemoglobin. 2005;29:133–40.CrossRefPubMedGoogle Scholar
  23. 23.
    Yang Y, Lou JW, Liu YH, He Y, Li DZ. Screening and diagnosis of Hb Quong Sze [HBA2: c.377T> C (or HBA1)] in a prenatal control program for thalassemia. Hemoglobin. 2014;38:158–60.CrossRefPubMedGoogle Scholar
  24. 24.
    Sanguansermsri T, Matragoon S, Changloah L, Flatz G. Hemoglobin Suan-Dok (α2 109(G16)LEU-ARGβ2). an unstable variant associated with α-thalassemia. Hemoglobin. 1979;3:161.CrossRefPubMedGoogle Scholar
  25. 25.
    Bang-Ce Y, Hongqiong L, Zhuanfong Z, et al. Simultaneous detection of alpha-thalassemia and beta-thalassemia by oligonucleotide microarray. Haematologica. 2004;89:1010–2.PubMedGoogle Scholar
  26. 26.
    Old J, Henderson S. Molecular diagnostics for haemoglobinopathies. Expert Opin Med Diagn. 2010;4:225–40.CrossRefPubMedGoogle Scholar
  27. 27.
    Harteveld CL, Kleanthous M, Traeger-Synodinos J. Prenatal diagnosis of hemoglobin disorders: present and future strategies. Clin Biochem. 2009;42:1767–79.CrossRefPubMedGoogle Scholar

Copyright information

© The Japanese Society of Hematology 2018

Authors and Affiliations

  1. 1.Department of Biomedical Sciences, Faculty of MedicinePrince of Songkla UniversitySongkhlaThailand
  2. 2.Department of Pathology, Faculty of MedicinePrince of Songkla UniversitySongkhlaThailand

Personalised recommendations